192 related articles for article (PubMed ID: 11214621)
1. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University.
El-Lamie IK; Shehata NA; Abou-Loz SK; El-Lamie KI
Eur J Gynaecol Oncol; 2000; 21(6):605-9. PubMed ID: 11214621
[TBL] [Abstract][Full Text] [Related]
2. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
[TBL] [Abstract][Full Text] [Related]
3. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.
Billmire D; Vinocur C; Rescorla F; Cushing B; London W; Schlatter M; Davis M; Giller R; Lauer S; Olson T;
J Pediatr Surg; 2004 Mar; 39(3):424-9; discussion 424-9. PubMed ID: 15017564
[TBL] [Abstract][Full Text] [Related]
4. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.
Williams S; Blessing JA; Liao SY; Ball H; Hanjani P
J Clin Oncol; 1994 Apr; 12(4):701-6. PubMed ID: 7512129
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients.
Mayordomo JI; Paz-Ares L; Rivera F; López-Brea M; López Martín E; Mendiola C; Díaz-Puente MT; Lianes P; García-Prats MD; Cortés-Funes H
Ann Oncol; 1994 Mar; 5(3):225-31. PubMed ID: 7514435
[TBL] [Abstract][Full Text] [Related]
7. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
[TBL] [Abstract][Full Text] [Related]
9. Malignant germ cell tumors of the ovary: a study of 20 cases.
Piura B; Dgani R; Zalel Y; Nemet D; Yanai-Inbar I; Cohen Y; Glezerman M
J Surg Oncol; 1995 Jul; 59(3):155-61. PubMed ID: 7609521
[TBL] [Abstract][Full Text] [Related]
10. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
Gershenson DM
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
[TBL] [Abstract][Full Text] [Related]
11. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors of the ovary: is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors?
Bafna UD; Umadevi K; Kumaran C; Nagarathna DS; Shashikala P; Tanseem R
Int J Gynecol Cancer; 2001; 11(4):300-4. PubMed ID: 11520369
[TBL] [Abstract][Full Text] [Related]
14. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of 27 ovarian tumors of low malignant potential.
Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
[TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.
Kanazawa K; Suzuki T; Sakumoto K
Am J Clin Oncol; 2000 Jun; 23(3):244-8. PubMed ID: 10857886
[TBL] [Abstract][Full Text] [Related]
19. Malignant ovarian germ cell tumors.
Chow SN; Yang JH; Lin YH; Chen YP; Lai JI; Chen RJ; Chen CD
Int J Gynaecol Obstet; 1996 May; 53(2):151-8. PubMed ID: 8735296
[TBL] [Abstract][Full Text] [Related]
20. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
